Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Home
»
Analysts
»
Charlie Haywood
Charlie Haywood
Follow
Stock Analyst at Bank of America Securities
(2.66)
# 2,954
Out of 4,659 analysts
10
Total ratings
62.5%
Success rate
11.9%
Average return
Main Sectors:
Healthcare
Top Industries:
Biotechnology
Stocks Rated by Charlie Haywood
Stock
Action
Price Target
Current
Upside
Ratings
Updated
GMAB
Genmab
Maintained:
Buy
n/a
$32.84
-
2
Aug 7, 2026
LON: 0MGB
Genmab A/S
Maintained:
Buy
kr 2,500
kr 2,104
+18.82%
7
Jun 30, 2026
LON: 0NZT
UCB SA
Upgraded:
Buy
€225.00
€215.30
n/a
1
Jul 2, 2025
GMAB
Genmab
Aug 7, 2026
Maintained:
Buy
Price Target:
n/a
Current: $32.84
Upside: -
2 Ratings
View All
LON: 0MGB
Genmab A/S
Jun 30, 2026
Maintained:
Buy
Price Target:
kr 2,500
Current: kr 2,104
Upside:
+18.82%
7 Ratings
View All
LON: 0NZT
UCB SA
Jul 2, 2025
Upgraded:
Buy
Price Target:
€225.00
Current: €215.30
Upside: n/a
1 Ratings
View All